Physician profile
Laura Lica
NPI 1104692664
$1,320.50
in general payments reported to CMS, 2019-2025
18 companies · $997 in 2025
The $997 reported for 2025 was more than what 83% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $324 · 2025: $997.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,321.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,320.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $250.23 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $218.94 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $174.69 | 2024-2025 | Lokelma, Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $122.35 | 2024-2025 | Lifevest |
| Edwards Lifesciences Corporation | $105.48 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Esperion Therapeutics, INC. | $56.49 | 2025 | Nexletol |
| Boehringer Ingelheim Pharmaceuticals, INC. | $55.02 | 2024-2025 | Jardiance |
| Amgen INC. | $51.97 | 2025 | Repatha |
| Merck Sharp & Dohme LLC | $48.21 | 2024-2025 | Verquvo |
| Novartis Pharmaceuticals Corporation | $42.49 | 2024-2025 | |
| Avadel Cns Pharmaceuticals, LLC | $34.36 | 2025 | Lumryz |
| Bridgebio Pharma, INC. | $30.48 | 2025 | Attruby |
| Pfizer INC. | $28.24 | 2024-2025 | |
| Philips North America LLC | $22.58 | 2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Janssen Pharmaceuticals, INC | $21.13 | 2024 | Xarelto |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $20.62 | 2025 | |
| Boston Scientific Corporation | $20.31 | 2025 | Watchman Flx |
| Kiniksa Pharmaceuticals International, Plc | $16.91 | 2024 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Lica listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.